048870 — Synergy Innovation Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual income statement for Synergy Innovation Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	R2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	68,947	30,705	86,539	83,215	90,605
Cost of Revenue
Gross Profit	28,857	6,181	39,541	31,603	38,104
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	58,786	29,482	63,612	68,230	74,401
Operating Profit	10,162	1,223	22,927	14,985	16,204
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-18,608	-1,561	14,674	26,711	21,797
Provision for Income Taxes
Net Income After Taxes	-19,485	-1,561	25,391	7,653	18,144
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-21,412	5,719	16,128	2,305	10,371
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-21,412	5,719	16,128	2,305	10,371
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-302	-72.1	231	29.2	121
Dividends per Share